[ORGANIZATION]
Protagonist Therapeutics
Featured in 4 tracked stories · first seen
Also covered in
-
FDA approves rusfertide for rare blood cancer polycythemia vera
[HEALTH] · 6 sources ·
-
Protagonist Therapeutics and PPL report earnings updates
[BUSINESS] · 2 sources ·